Innovations in hematopoietic stem-cell mobilization: a review of the novel CXCR4 inhibitor motixafortide

Hematopoietic stem-cell transplantation (HCT) and stem-cell–based gene therapies rely on the ability to collect sufficient CD34+ hematopoietic stem and progenitor cells (HSPCs), typically via peripheral blood mobilization. Commonly used HSPC mobilization regimens include single-agent granulocyte col...

Descripción completa

Detalles Bibliográficos
Autores principales: Crees, Zachary D., Rettig, Michael P., DiPersio, John F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214082/
https://www.ncbi.nlm.nih.gov/pubmed/37250913
http://dx.doi.org/10.1177/20406207231174304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214082/
https://www.ncbi.nlm.nih.gov/pubmed/37250913
http://dx.doi.org/10.1177/20406207231174304

Ejemplares similares